James M Peacock

Author PubWeight™ 29.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Arterioscler Thromb Vasc Biol 2007 2.54
2 The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin Chem 2007 2.03
3 Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2008 1.37
4 Effect of influenza vaccine on markers of inflammation and lipid profile. J Lab Clin Med 2005 1.31
5 Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009 1.19
6 Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. Clin Chem 2004 1.17
7 Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 2007 1.17
8 Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J Nutr 2007 1.15
9 ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) 2008 1.15
10 Utility of dysphagia screening results in predicting poststroke pneumonia. Stroke 2010 1.13
11 Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Diabetes Care 2008 1.09
12 The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. Eur J Hum Genet 2008 1.09
13 Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Metabolism 2008 1.08
14 Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 2002 0.96
15 Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease. Atherosclerosis 2008 0.92
16 The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res 2008 0.90
17 Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota. Pancreas 2012 0.89
18 Evidence for a gene influencing fasting LDL cholesterol and triglyceride levels on chromosome 21q. Atherosclerosis 2004 0.87
19 Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study. Circ J 2012 0.87
20 Refined mapping of suggestive linkage to renal function in African Americans: the HyperGEN study. Am J Hum Genet 2002 0.85
21 Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence. Cancer Epidemiol Biomarkers Prev 2007 0.85
22 Suggestion for linkage of chromosome 1p35.2 and 3q28 to plasma adiponectin concentrations in the GOLDN Study. BMC Med Genet 2009 0.84
23 Impact of an electronic medical record-based clinical decision support tool for dysphagia screening on care quality. Stroke 2012 0.83
24 Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Cerebrovasc Dis 2012 0.82
25 Thrombolytic Treatment After Acute Ischemic Stroke Results from the Minnesota Stroke Registry and Opportunities to Improve Care. J Vasc Interv Neurol 2008 0.79
26 beta2-adrenergic receptor polymorphism and venous thromboembolism. Thromb Haemost 2008 0.76
27 Stroke Prevention: The Best Outcome after a Transient Ischemic Attack. Results from the Minnesota Stroke Registry and Opportunities to Improve Care. J Vasc Interv Neurol 2008 0.75
28 The FReedom from Ischemic Events-New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease. BMC Cardiovasc Disord 2013 0.75